After myocardial infarction carvedilol improves insulin resistance compared to metoprolol

Clinical Research in Cardiology

Volumn 95, Issue 2, 2006, Pages 99-104

  Basat, O ^a,b   Ucak, S ^a   Seber, S ^a   Oztekin, E ^a   Altuntas, Y ^a  

^a SISLI ETFAL TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b NONE   (Turkey)

Author keywords

Carvedilol; Insulin resistance; Metoprolol; Myocardial infarction

Indexed keywords

ACETYLSALICYLIC ACID; ATORVASTATIN; C PEPTIDE; CARVEDILOL; INSULIN; ISOSORBIDE MONONITRATE; METOPROLOL; RAMIPRIL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HEART INFARCTION; HOMEOSTASIS; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; ST SEGMENT ELEVATION; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL;

ADRENERGIC ALPHA-ANTAGONISTS; ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; C-PEPTIDE; CARBAZOLES; CHOLESTEROL, LDL; FEMALE; GLUCOSE CLAMP TECHNIQUE; HUMANS; INSULIN RESISTANCE; MALE; METOPROLOL; MIDDLE AGED; MYOCARDIAL INFARCTION; PROPANOLAMINES; TRIGLYCERIDES;

EID: 32944468167     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-006-0336-4     Document Type: Article

References (22)

1. Abbasi F, Brown BW Jr, Lamendola C et al. (2002) Relationship between obesity, insulin resistance, and coronary heart disease risk. J Am Coll Cardiol 40:937-943
2. Arad Y, Newstein D, Cadet F et al. (2001) Association of multiple risk factors and insulin resistance with increased prevalance of asymptomatic coronary artery disease by an electron-beam computed tomographic study. Arterioscler Thromb Vasc Biol 21:2051-2058
3. Bakris GL, Fonseca V, Katholi RE et al. GEMINI Investigators (2004) Metabolic effects of carvedilol vs metoprolol in patients with type 2 diabetes mellitus and hypertension: a randomized controlled trial. JAMA 10:2227-2236
4. Bavenholm P, de Faire U, Landou C et al. (1998) Progression of coronary artery disease in young male post-infarction patients is linked to disturbances of carbohydrate and lipoprotein metabolism and to impaired fibrinolytic function. Eur Heart J 19:402-410
5. Dargie HJ (2001) Effect of carvedilol on outcome after myocardial infarction in patients with left ventricular dysfunction: the CAPRICORN randomized trial. Lancet 357:1385-1390
6. De Fronzo RA, Ferrannini E (1991) Insulin resistance a maltifaceted syndrome responsible for NIDDM, obesity, hypertension and dyslipidemia. Diab Care 14:173-177
7. Freemantle N, Cleland J, Young P et al. (1999) Beta blockade after myocardial infarction: systematic review and meta regression analysis. BMJ 26:1730-1737
8. Gilbert EM, Abraham WT, Olsen S et al. (1996) Comparative hemodynamic, left ventricular functional, and antiadrenergic effects of chronic treatment with metoprolol versus carvedilol in the failing heart. Circulation 94:2817-2825
9. Hamburger SA, Barone FC, Feuerstein GZ et al. (1991) Carvedilol (Kredex) reduces infarct size in canine model of myocardial infarction. Pharmacology 43:113-120
10. Jacob S, Balletshofer B, Henriksen EJ et al. (1999) Beta-blocking agents in patients with insulin resistance: effects of vasodilating beta blockers. Blood Pres 8:261-268
11. Jacob S, Rett K, Henriksen EJ (1998) Antihypertensive therapy and insulin sensitivity: do we have to redefine the role of beta-blocking agents? Am J Hypertens 11:1258-1265
12. Jacob S, Rett K, Wicklmayr M et al. (1996) Differential effect of chronic treatment with two beta-blocking agents on insulin sensitivity: the carvedilol-metoprolol study. J Hypertens 14:489-494
13. Katsuki A, Sumida Y, Gabazza EC et al. (2001) Homeostasis model assessment is a reliable indicator of insulin resistance during follow-up of patients with type 2 diabetes. Diabetes Care 24:362-365
14. Otterstad J, Ford I (2002) The effect of carvedilol in patients with impaired left ventricular systolic function following an acute myocardial infarction. How do the treatment effects on total mortality and recurrent myocardial infarction in CAPRICORN compare with previous beta blocker trials? Eur J Heart Fail 4:501
15. Pollare T, Lithell H, Selinus I et al. (1989) Sensitivity to insulin during treatment with atenolol and metoprolol: a randomized, double blind stud of effects on carbohydrate and lipoprotein metabolism in hypertensive patients. BMJ 298:1152-1157
16. Rabkin SW (1993) Mechanisms of action of adrenergic receptor blockers on lipids during antihypertensive drug treatment. J Clin Pharmacol 33:286-291
17. Reaven GM (1998) Role of insulin resistance in human disease. Diabetes 37:1595-1607
18. Refsgaard J, Thomsen C, Andreasen F et al. (2002) Carvedilol does not alter the insulin sensitivity in patients with congestive heart failure. Eur J Heart Fail 4:445-453
19. Reneland R, Alvarez E, Andersson PE et al. (2000) Induction of insulin resistance by beta-blockade but not ACE-inhibition: long-term treatment with atenolol or trandolapril. J Hum Hypertens; 14:175-180
20. Rocchini AP, Moorehead C, Katch V et al. (1992) Forearm resistance vessel adnormalties and insulin resistance in obese adolescents. Hypertension 19:615-620
21. Sekiguchi M, Kurabayashi M, Adachi H et al. (2004) Usefulness of insulin resistance measured by homeostasis model assessment in predicting restenosis after coronary stent placement in nondiabetic patients. Am J Cardiol 93:920-922
22. Sokolov EI (2002) Hyperinsulinemia and insulin resistance in pathogenesis of atherosclerosis and ischemic heart disease. Ter Arkh 74:40-43